Abstract
Human bocaviruses (HBoVs) are recently described as human emergent viruses, especially in young children. In this study, we undertook a systematic review and meta-analysis to estimate their prevalence in Europe. PubMed, Web of Science and Scopus databases were systematically screened for clinical studies, up to October 2020. Study eligibility criteria were primary full-text articles from clinical studies, conducted using valid screening test methods and published in peer-reviewed journals, in English or Spanish and from European countries. The overall pooled prevalence, prevalence by country as well as the prevalence of HBoV as a single or co-pathogen were estimated using a random-effects model. Sub-group and meta-regression analyses explored potential sources of heterogeneity in the data. A total of 35 studies involving 32,656 subjects from 16 European countries met the inclusion criteria. Heterogeneity (I2= 97.0%, p <5 years old. The OR value of 1.77 (95%CI 1.13-2.77; p <5 years old is a risk factor for HBoV infection. This study showed that HBoV has a moderate prevalence among European countries.
Author supplied keywords
Cite
CITATION STYLE
Polo, D., Lema, A., Gándara, E., & Romalde, J. L. (2022, September 1). Prevalence of human bocavirus infections in Europe. A systematic review and meta-analysis. Transboundary and Emerging Diseases. John Wiley and Sons Inc. https://doi.org/10.1111/tbed.14233
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.